Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Idiopathic hypersomnia years after the diagnosis

K. Šonka, E. Feketeová, S. Nevšímalová, EM. Horvat, I. Příhodová, S. Dostálová, K. Galušková, M. Milata, J. Bušková, M. Susta

. 2024 ; 33 (2) : e14011. [pub] 20230812

Language English Country England, Great Britain

Document type Journal Article

Grant support
Charles University Cooperatio program in neuroscience
NU20-04-00088 Ministry of Health of the Czech Republic

Little attention has been paid to the long-term development of idiopathic hypersomnia symptoms and idiopathic hypersomnia comorbidities. The aim of this study was to describe the general health of patients with idiopathic hypersomnia years after the initial diagnosis, focusing on current subjective hypersomnolence and the presence of its other possible causes. Adult patients diagnosed with idiopathic hypersomnia ≥ 3 years ago at sleep centres in Prague and Kosice were invited to participate in this study. A total of 60 patients were examined (age 47.3 ± SD = 13.2 years, 66.7% women). In all participants, their hypersomnolence could not be explained by any other cause but idiopathic hypersomnia at the time of diagnosis. The mean duration of follow-up was 9.8 + 8.0 years. Fifty patients (83%) reported persisting hypersomnolence, but only 33 (55%) had no other disease that could also explain the patient's excessive daytime sleepiness and/or prolonged sleep. In two patients (3%), the diagnosis in the meantime had changed to narcolepsy type 2, and 15 patients (25%) had developed a disease or diseases potentially causing hypersomnolence since the initial diagnosis. Complete hypersomnolence resolution without stimulant treatment lasting longer than 6 months was reported by 10 patients (17%). To conclude, in a longer interval from the diagnosis of idiopathic hypersomnia, hypersomnolence may disappear or may theoretically be explained by another newly developed disease, or the diagnosis may be changed to narcolepsy type 2. Thus, after 9.8 years, only 55% of the examined patients with idiopathic hypersomnia had a typical clinical picture of idiopathic hypersomnia without doubts about the cause of the current hypersomnolence.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006631
003      
CZ-PrNML
005      
20240423155418.0
007      
ta
008      
240412s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jsr.14011 $2 doi
035    __
$a (PubMed)37572055
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Šonka, Karel $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000157739656 $7 jn99240001644
245    10
$a Idiopathic hypersomnia years after the diagnosis / $c K. Šonka, E. Feketeová, S. Nevšímalová, EM. Horvat, I. Příhodová, S. Dostálová, K. Galušková, M. Milata, J. Bušková, M. Susta
520    9_
$a Little attention has been paid to the long-term development of idiopathic hypersomnia symptoms and idiopathic hypersomnia comorbidities. The aim of this study was to describe the general health of patients with idiopathic hypersomnia years after the initial diagnosis, focusing on current subjective hypersomnolence and the presence of its other possible causes. Adult patients diagnosed with idiopathic hypersomnia ≥ 3 years ago at sleep centres in Prague and Kosice were invited to participate in this study. A total of 60 patients were examined (age 47.3 ± SD = 13.2 years, 66.7% women). In all participants, their hypersomnolence could not be explained by any other cause but idiopathic hypersomnia at the time of diagnosis. The mean duration of follow-up was 9.8 + 8.0 years. Fifty patients (83%) reported persisting hypersomnolence, but only 33 (55%) had no other disease that could also explain the patient's excessive daytime sleepiness and/or prolonged sleep. In two patients (3%), the diagnosis in the meantime had changed to narcolepsy type 2, and 15 patients (25%) had developed a disease or diseases potentially causing hypersomnolence since the initial diagnosis. Complete hypersomnolence resolution without stimulant treatment lasting longer than 6 months was reported by 10 patients (17%). To conclude, in a longer interval from the diagnosis of idiopathic hypersomnia, hypersomnolence may disappear or may theoretically be explained by another newly developed disease, or the diagnosis may be changed to narcolepsy type 2. Thus, after 9.8 years, only 55% of the examined patients with idiopathic hypersomnia had a typical clinical picture of idiopathic hypersomnia without doubts about the cause of the current hypersomnolence.
650    _2
$a dospělí $7 D000328
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mužské pohlaví $7 D008297
650    12
$a idiopatická hypersomnie $x diagnóza $x epidemiologie $x farmakoterapie $7 D020177
650    12
$a poruchy nadměrné spavosti $x diagnóza $x epidemiologie $x komplikace $7 D006970
650    12
$a narkolepsie $x diagnóza $x epidemiologie $7 D009290
650    _2
$a komorbidita $7 D015897
650    _2
$a pozornost $7 D001288
655    _2
$a časopisecké články $7 D016428
700    1_
$a Feketeová, Eva $u Department of Neurology, Faculty of Medicine, University of P.J. Šafárik and University Hospital of L. Pasteur, Košice, Slovak Republic $1 https://orcid.org/0000000277463797 $7 xx0070674
700    1_
$a Nevšímalová, Soňa $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000300833742 $7 nlk19990073606
700    1_
$a Horvat, Eszter Maurovich $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0009000857840947
700    1_
$a Příhodová, Iva $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000233275487 $7 xx0104798
700    1_
$a Dostálová, Simona $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000244219958 $7 xx0075780
700    1_
$a Galušková, Karolína $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000293134571
700    1_
$a Milata, Martin $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic $1 https://orcid.org/0009000199826421
700    1_
$a Bušková, Jitka $u National Institute of Mental Health, Klecany and Third Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000185908031
700    1_
$a Susta, Marek $u St. Elisabeth University, Bratislava, Slovak Republic $1 https://orcid.org/0000000325444751
773    0_
$w MED00002940 $t Journal of sleep research $x 1365-2869 $g Roč. 33, č. 2 (2024), s. e14011
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37572055 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155415 $b ABA008
999    __
$a ok $b bmc $g 2080941 $s 1216398
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 33 $c 2 $d e14011 $e 20230812 $i 1365-2869 $m Journal of sleep research $n J Sleep Res $x MED00002940
GRA    __
$p Charles University Cooperatio program in neuroscience
GRA    __
$a NU20-04-00088 $p Ministry of Health of the Czech Republic
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...